Judith Böhm,Martin Windpessl,Matthias Huemer et al.
Judith Böhm et al.
Integrating palliative care principles into clinical practice in nephrology has become an urgent need with the growing number of patients with advanced age and frailty reaching end-stage kidney disease (ESKD). While principles of palliative...
Monoclonal gammopathy of clinical significance: a guide for nephrologists [0.03%]
临床意义单克隆免疫球蛋白血症:肾病专家指导手册
Patrick Hofmann,Sujal I Shah,Helmut G Rennke et al.
Patrick Hofmann et al.
Monoclonal gammopathy of undetermined significance (MGUS) is commonly encountered in older individuals. MGUS, by definition, is a benign finding where an expanded population of clonal plasma and B-cells produces a monoclonal antibody that i...
Impact of continuous glucose monitoring on glycemic control and biochemical cardiovascular risk factors in kidney transplant recipients with type 1 diabetes [0.03%]
持续葡萄糖监测对I型糖尿病肾移植受者的血糖控制及生化心血管危险因素的影响
Monika Widera,Aleksander J Owczarek,Aureliusz Kolonko et al.
Monika Widera et al.
Aims: To compare biochemical risk factors for cardiovascular disease (CVD) in kidney transplant recipients (KTx) with type 1 diabetes (T1D) who used continuous glucose monitoring (CGM) devices or underwent simultaneous ki...
Clinical phenotypes and etiologic subtypes of thrombotic microangiopathy in systemic lupus erythematosus [0.03%]
系统性红斑狼疮血栓性微血管病的临床表型及病因亚型
André Fortanell-Meza,Daniela E Sánchez-Mejía,Ana Barrera-Vargas et al.
André Fortanell-Meza et al.
Background: Thrombotic microangiopathy (TMA) is a rare and severe complication of systemic lupus erythematosus (SLE). While classically defined by microangiopathic hemolytic anemia, thrombocytopenia, and organ damage, TMA...
Creatine supplementation in patients with kidney disease - harm or benefit? [0.03%]
肌酸补充剂在肾脏病患者中的应用——弊大于利吗?
Juliana Paula Pereira,Viviane O Leal,Pricilla Trigueira et al.
Juliana Paula Pereira et al.
Creatine is one of the most widely used nutritional supplements and has a well-established role in cellular energy metabolism, skeletal muscle performance, and exercise capacity. More recently, growing evidence suggests that its biological ...
Urea vs. tolvaptan for hospitalized patients with SIADH [0.03%]
尿素与托伐普坦治疗综合症_of_ inappropriate_抗利尿激素分泌综合征住院患者的效果比较
Marie Heller,Kathrin Marx,Ulrike Hoffmann et al.
Marie Heller et al.
Rationale: Hyponatremia is the most common electrolyte disorder found in hospitalized patients and is associated with an increased mortality. Urea has been proposed as an alternative to vasopressin receptor antagonists (V...
Mahtab Mashayekhi,Jianbo Qing,Giv Heidari-Bateni et al.
Mahtab Mashayekhi et al.
Obesity is a global epidemic and is increasingly recognized as a direct and independent risk factor for chronic kidney disease (CKD), beyond its established associations with diabetes and hypertension. Excess adiposity promotes kidney injur...
Proteinuria remission and long-term kidney outcome in children with IgA nephropathy [0.03%]
儿童IgA肾病患者蛋白尿缓解与长期肾脏预后的关系研究
Rosanna Coppo,Giuseppe Lucisano,Licia Peruzzi et al.
Rosanna Coppo et al.
Background: KDIGO and IPNA guidelines indicate a target of proteinuria < 0.2 g/day/1.73m2 in children with Immunoglobulin A nephropathy (IgAN). However, the value of proteinuria remission to this threshold was limited to ...
Filtering the 2026 ACC/AHA guidelines of dyslipidaemia management: what nephrologists need to know [0.03%]
血脂异常管理中2026年美国心脏病学会/美国心脏协会指南的精华:肾脏专家需要知道的内容
Amaryllis H Van Craenenbroeck,Patrick B Mark,Jose M Valdivielso
Amaryllis H Van Craenenbroeck
C5a/C5aR1 mediates AKI-CKD transition by enhancing autophagy [0.03%]
C5a/C5aR1通过增强自噬介导急性肾损伤向慢性肾脏疾病转化
Jingyuan Ma,Wai Han Yiu,Sarah W Y Lok et al.
Jingyuan Ma et al.
Background: Excessive production of complement C5a detected in acute kidney injury (AKI) and during the development of chronic kidney disease (CKD) suggests its possible role in CKD progression, but the underlying mechani...